1. Home
  2. KLTO vs WKHS Comparison

KLTO vs WKHS Comparison

Compare KLTO & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • WKHS
  • Stock Information
  • Founded
  • KLTO 2019
  • WKHS 2007
  • Country
  • KLTO United States
  • WKHS United States
  • Employees
  • KLTO N/A
  • WKHS N/A
  • Industry
  • KLTO
  • WKHS Auto Manufacturing
  • Sector
  • KLTO
  • WKHS Consumer Discretionary
  • Exchange
  • KLTO NYSE
  • WKHS Nasdaq
  • Market Cap
  • KLTO 5.9M
  • WKHS 6.0M
  • IPO Year
  • KLTO N/A
  • WKHS N/A
  • Fundamental
  • Price
  • KLTO $0.71
  • WKHS $1.14
  • Analyst Decision
  • KLTO
  • WKHS Hold
  • Analyst Count
  • KLTO 0
  • WKHS 1
  • Target Price
  • KLTO N/A
  • WKHS $15.62
  • AVG Volume (30 Days)
  • KLTO 84.5M
  • WKHS 510.7K
  • Earning Date
  • KLTO 08-15-2025
  • WKHS 08-19-2025
  • Dividend Yield
  • KLTO N/A
  • WKHS N/A
  • EPS Growth
  • KLTO N/A
  • WKHS N/A
  • EPS
  • KLTO N/A
  • WKHS N/A
  • Revenue
  • KLTO N/A
  • WKHS $5,917,985.00
  • Revenue This Year
  • KLTO N/A
  • WKHS $54.16
  • Revenue Next Year
  • KLTO N/A
  • WKHS $85.00
  • P/E Ratio
  • KLTO N/A
  • WKHS N/A
  • Revenue Growth
  • KLTO N/A
  • WKHS N/A
  • 52 Week Low
  • KLTO $0.11
  • WKHS $0.81
  • 52 Week High
  • KLTO $3.91
  • WKHS $28.13
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • WKHS 58.99
  • Support Level
  • KLTO N/A
  • WKHS $0.93
  • Resistance Level
  • KLTO N/A
  • WKHS $1.20
  • Average True Range (ATR)
  • KLTO 0.00
  • WKHS 0.09
  • MACD
  • KLTO 0.00
  • WKHS 0.03
  • Stochastic Oscillator
  • KLTO 0.00
  • WKHS 79.08

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: